Toxic Shock Syndrome Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Adjunctive Clindamycin Versus Linezolid for β-lactam Treated Patients With Invasive Group A Streptococcal Infections
Conditions: Streptococcal Sepsis; Invasive Group A Beta-Haemolytic Streptococcal Disease; Necrotizing Soft Tissue Infection; Infection, Bloodstream; Infection, Bacterial; Streptococcal Toxic Shock Syndrome Interventions: Drug: Linezolid; Drug: Clindamycin Sponsors: National Institutes of Health Clinical Center (CC); Emory University Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
Prodromes of Menstrual Staphylococcal Toxic Shock
Conditions: Toxic Shock Syndrome Staphylococcal Interventions: Other: Identification of symptoms of menstrual staphylococcal toxic shock in last three menstrual period; Other: Identification of symptoms of menstrual in control patient in the last three menstrual period Sponsors: Hospices Civils de Lyon Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2023 Category: Research Source Type: clinical trials
